CJC-1295 with DAC is a synthetic analog of Growth Hormone Releasing Hormone (GHRH), modified with a Drug Affinity Complex (DAC) to significantly extend its half-life in circulation. The peptide is studied for its ability to support stable and prolonged release of endogenous growth hormone (GH) from the pituitary gland.
Key Research Areas:
-
Long-term endogenous GH secretion enhancement
-
Study of DAC-bound peptides and albumin interaction
-
Muscle metabolism and tissue regeneration models
-
Comparative studies with CJC-1295 (non-DAC)
-
GH pulsatility and pituitary function studies
Note: This product is intended for laboratory research only. Not for human or veterinary use.

There are no reviews yet.